CLINICAL_TRIALS
trial_result
· 2017-04-17
Clinical Trial Update: Zinc Supplementation on Cellular Immunity in Thalassemia Major [Phase 4]
Summary
Phase 4 study evaluating zinc supplementation on cellular immunity in thalassemia major has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fakultas Kedokteran Universitas Indonesia | Conditions: Thalassemia, Splenectomy; Status | Phase 4 | Status: COMPLETED